Prognostic value of molecular classification in metastatic breast cancer confirmed

Source : https://www.eurekalert.org/pub_releases/2021-03/uob-pvo032921.php

Barcelona researchers at the Hospital Clínic-IDIBAPS Research Institute, the University of Barcelona and the SOLTI academic cancer research group have shown that the molecular classification of breast cancer, which divides it into four subtypes (Luminal A, Luminal B, HER2-enriched and Basal-like) is useful for predicting the benefits of treatment in patients with advanced hormone-sensitive breast cancer.